Clinical trials
Peripheral Arterial Disease trials in Italy
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
78 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2005 | 2 |
| 2006 | 2 |
| 2007 | 2 |
| 2010 | 3 |
| 2011 | 1 |
| 2012 | 7 |
| 2013 | 4 |
| 2014 | 3 |
| 2015 | 5 |
| 2016 | 3 |
| 2017 | 2 |
| 2018 | 3 |
| 2019 | 7 |
| 2020 | 5 |
| 2021 | 8 |
| 2022 | 4 |
| 2023 | 10 |
| 2024 | 5 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 36 |
| Unknown status | 22 |
| Recruiting | 13 |
| Active, not recruiting | 4 |
| Terminated | 2 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 4 |
| Bayer | 3 |
| Biotronik AG | 3 |
| CID S.p.A. | 3 |
| EndoCore Lab s.r.l. | 3 |
| Federico II University | 3 |
| Ospedale San Donato | 3 |
| University of Catanzaro | 3 |
| W.L.Gore & Associates | 3 |
| AstraZeneca | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Peripheral Arterial Disease | 78 |
| Chronic Limb-Threatening Ischemia | 8 |
| Atherosclerosis | 7 |
| Coronary Artery Disease | 6 |
| Peripheral Vascular Diseases | 5 |
| Cardiovascular Diseases | 4 |
| Diabetes Mellitus | 4 |
| Diabetes Mellitus, Type 2 | 3 |
| Heart Diseases | 3 |
| Intermittent Claudication | 3 |
Trials
Showing 1 to 25 of 78. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.